Schimmelpennink Evert B. bought LENZ
March 27, 2026 · Form 4 insider transaction
Schimmelpennink Evert B. bought 28,089 shares of LENZ Therapeutics, Inc. at $8.95 per share, a transaction worth $251.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,089
Price
$8.95
Total value
$251.4K
InsiderSchimmelpennink Evert B.
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 27, 2026
Filing dateMarch 30, 2026
Shares owned after77,289
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the weighted average share price of an aggregate total of 28,089 shares purchased in the price range of $8.80 to $9.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.